![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Sonoma’s Post-Laser Skin Therapy Gel Cleared by FDA
Sonoma’s Post-Laser Skin Therapy Gel Cleared by FDA
![ClearanceStamp_Gray.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Gray.gif?t=1576043982&width=430)
April 6, 2018
Sonoma Pharmaceutical’s antimicrobial gel received 510(k) clearance from the FDA to treat the skin of post-nonablative laser therapy and post-microdermabrasion therapy patients, in addition to treating post-superficial chemical peels.
The product is intended for dermatologists and aesthetic clinicians to manage medical procedures and post-procedure itch and pain associated with procedures like laser skin resurfacing.
The antimicrobial gel promotes advanced healing and protection against secondary infections that could occur after treatment.
Upcoming Events
-
21Oct